Cancer 7 Flashcards

1
Q

what is the definition of angiogenesis?

A
  • Angiogenesis is the formation of a new blood vessel from pre=existing blood

vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the 3 ways to make blood vessels?

A
  • Vasculogenesis

in the embryo, the contribution of bone marrow progenitor cells is very important in the early stages of blood vessel formation

  • Angiogenesis

the most common way in which new blood vessels are formed eg. in wound healing or in the menstrual cycle

  • Arteriogenesis

collateral growth that is dependent on shear stress and external factors like macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the regulators of angiogenesis?

A
  • there is a large number of regulators of angiogenesis required
  • we need both inhibitors and activators
  • some are crucial eg. VEGF
  • some or only required for modulation eg. VWF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the stages of sprouting angiogenesis?

A
  • tip/ stalk cell selection
  • tip cell drives the sprouting
  • the stalk cells proliferate
  • branching coordination
  • stalk elongation
  • tip cell fusion
  • lumen formation
  • perfusion and vessel maturation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the most important signal to form new blood vessels?

A
  • hypoxia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how does hypoxia trigger angiogenesis?

A

in the presence of oxygen =

  • HIF is inhibited by binding to Von Hippel - Lindau factor

in the case of hypoxia =

  • the proteins detach
  • the von Hippel - Lindau is removed from HIF
  • HIF goes into the nucleus
  • binds to DNA
  • drives the expression of genes that promote angiogenesis eg. VGEF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is VGEF?

vascular endothelial growth factors

A
  • family of 5 members
  • VEGF-A, VEGF-B, VEGF-C, VEGF-D and placental growth factor (PIGF)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the VGEF receptors?

A
  • three tyrosine receptors
  • VEGFR 1, VEGFR 2, VEGFR 3 and co-receptors neuropilin
  • VEGFR 2 is a major mediator of the VEGF dependent angiogenesis activating signaling pathways that regulate endothelial cell migration, survival , and proliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the co-receptors for VEGF?

A
  • neuropilin - 1
  • neuropilin - 2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the role of VEGF in angiogenesis?

A
  • VEGF is produced by something in the environment
  • VEGF binds to VEGF receptor in the environment
  • the cell that VEGF binds to becomes the tip cell
  • the tip cells tell the surrounding cells to become stalk cells
  • tip cells lead the outgrowth of blood- vessel sprouts towards gradients of VEGF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the canonical notch pathway?

A
  • the Notch ligand ( Delta-like ligand 4 (Dll4)) and Notch receptor bind
  • this binding causes the cleavage of the notch intracellular domain (NICD)
  • NICD goes into the nucleus and acts as a transcriptional regulator RBP- J and regulates transcription
  • When a tip cell is chosen, it begins to express notch ligand which binds to the stalk cells’ notch receptors, to identify the tip cell
  • The stalk cells then begin to divide and push the tip cell towards the growth factor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how does VEGF affect the Canonical Notch Signalling Pathway?

A
  • VEGF will activate endothelial cells in a capillary and increase expression of Dll4
  • Dll4 then drives the Notch signaling and inhibits the expression of VEGFR2 in the adjacent cell
  • By doing this, the cells on either side of the tip cell will then recognize their role as stalk cells that have to divide and push the tip cell forward
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how does sprout outgrowth take place?

A
  • once the tip cells and stalk cells have been identified the sprout needs to progress further
  • The cells will interact with the ECM and there will be guidance systems in place
  • Macrophages also have an important role in vessel anastomosis
  • macrophages carve out tunnels in the ECM thereby providing avenues for subsequent capillary infiltration
  • Tissue-resident macrophages were shown to be associated with angiogenic tip cells during anastomosis
  • macrophages appear to help stabilize newly formed vessels by promoting tip cell fusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the role of platelets in angiogenesis?

A
  • platelets are modulators of angiogenesis
  • they contain both initiators and inhibitors for angiogenesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the stabilization and quiescence stage of angiogenesis?

A
  • once the tip cells have fused and the stalk cells are separating to form a patent tube, the new vessel needs to stabilize
  • stabilization involves reforming the endothelial monolayer barrier and recruiting neural cells
  • as well as switching off the active angiogenesis process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how are the junctions between the cells formed?

A
  • There are proteins (cadherins) on the membranes of both cells that bind in a homophilic way
17
Q

why are the cadherin interactions at the junctions so important?

A
  • Cadherin is an important protein that lines the junctions of endothelial cells
  • VE-Cadherin is essential for vessel stabilization and quiescence
  • the homophilic interaction between the cadherins on the endothelial cells mediates the adhesion between endothelial cells and is important for signaling
  • The cadherin interactions are also important in contact inhibition of cell growth
  • cadherins also promote the survival of the endothelial cells
18
Q

why are pericytes recruited at the junctions?

A
  • they produce a load of proteins that are involved in stabilizing the vessel
  • specifically they produce Angiopoietin 1 that goes on to control junctional systems eg. the notch system
  • The angiopoietin/Tie- 2 system is specific to the endothelium
19
Q

what is the role of angiopoietin-Tie2 system?

explain the function of Angiopoietin 1?

explain the function of Angiopoietin 2?

A
  • The angiopoietin- Tie2 system is required to modulate the activity of the endothelial cells and revert them to quiescence (dormancy)
  • Tie 2 is a receptor that binds to Angiopoietin 1
  • when angiopoietin 1 binds to Tie 2 promotes quiescence
  • angiopoietin 2 is released when you need to form new blood vessels, respond to inflammation or destabilize the vasculature
  • Angiopoietin 2 antagonizes Ang-1 signaling and causes angiogenesis
20
Q

when do tumours require angiogenesis?

A
  • Tumours <1 mm^3 receive oxygen and nutrients by diffusion from host vasculature
  • when tumors grow larger than this they require new vessel networks
  • Tumors secrete angiogenic factors that stimulate the formation of new blood vessels
  • a newly vascularized tumor no longer depends on the host vasculature this , therefore facilitates its progressive growth
21
Q

what is the angiogenic switch?

A
  • there is a point at which the tumour gets to a certain size where diffusion is no longer sufficient, so some cells of the tumour become hypoxic and send for angiogenic signals
22
Q
A
23
Q

why are the tumour blood vessels not properly formed?

A
  • these are not properly formed because the angiogenesis signals are hypoxic
  • the signals are imbalenced
24
Q

what are the features of tumour blood vessels?

A
  • Irregularly shaped, dilated, tortuous
  • not organized into venules arteries and capillaries
  • Leaky and haemorrhagic
  • Perivascular cells often become
    loosely associated

*

25
Q

what is the role of platelets in tumor angiogenesis

A
  • there is a link between cancer progression and thromboctyosis
  • activated platelets are a source of pro-angiogenic factors
  • tumors cause platelet activation which might potentially be promoting angiogenesis
26
Q

how does anti - VGEF antibodies treatment work?

(Avastin)

A
  • This is also called Bevacizumab
  • this works by preventing angiogenesis by blocking VGEF
  • however Avastin has limited efficacy and lots of side effects

o Proteinuria

o Venous thrombosis

o Haemorrhage

o Wound healing complications

o perforation Hypertension

the drug has lots of side effects because VEGF is essential for the homeostasis of the endothelium

there was no overall survival advantage to chemotherapy

27
Q

what are the two main methods of the tumor being resistant to VEGF blockade?

A
  • The tumour adopts an evasive strategy and adapts to bypass the specific angiogenic blockade
  • Intrinsic or pre-existing difference = the idea that a particular tumour in particular place in a particular person, was not very sensitive to VEGF anyway, so knocking out VEGF made little difference
28
Q

who did anti-angiogenetic medication aid?

A
  • aided those with Age-related macular degeneration (AMD)
29
Q

who might pro-angiogenic therapy help?

A
  • may help people following an occlusion of an artery
  • There have been attempts to inject VEGF into the cardiac tissue soon after occlusion with the hope of stimulating neovascularisation that will reduce the damage due to ischaemia
30
Q

how does anti VEGF therapy help those with Age-related macular degeneration?

A
  • Though Avastin wasn’t designed for AMD, some clinicians tried it out and found that it was effective in AMD
31
Q

what is tumour on a chip?

A
  • tumours are complex 3D structures
  • tumour on a chip aims to replicate this environment
  • it would be much more reliable than animal testing/drug screens
  • we can grow our own blood vessels on the chip